Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study-Reference-Cited by-同舟云学术

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study

Published:2016-12-19 Issue:1 Volume:108 Page:73-80
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Suzuki Nobuaki¹,Hazama Shoichi¹,Iguchi Haruo²,Uesugi Kazuhiro²,Tanaka Hiroaki³,Hirakawa Kosei³,Aruga Atsushi⁴,Hatori Takashi⁴,Ishizaki Hidenobu⁵,Umeda Yuzo⁶,Fujiwara Toshiyoshi⁶,Ikemoto Tetsuya⁷,Shimada Mitsuo⁷,Yoshimatsu Kazuhiko⁸,Shimizu Ryoichi⁹,Hayashi Hiroto¹⁰,Sakata Koichiro¹¹,Takenouchi Hiroko¹,Matsui Hiroto¹,Shindo Yoshitaro¹,Iida Michihisa¹,Koki Yasunobu¹²,Arima Hideki¹²,Furukawa Hiroyuki¹²,Ueno Tomio¹,Yoshino Shigefumi¹,Nakamura Yusuke¹³,Oka Masaaki¹⁴,Nagano Hiroaki¹

Affiliation:

1. Department of Gastroenterological, Breast and Endocrine Surgery; Yamaguchi University Graduate School of Medicine; Ube Japan

2. Clinical Research Center; Shikoku Cancer Center, NHO; Matsuyama Japan

3. Department of Surgical Oncology; Osaka City University Graduate School of Medicine; Osaka Japan

4. Institute of Gastroenterology; Tokyo Women's Medical University; Tokyo Japan

5. Department of Surgical Oncology and Regulation of Organ Function; Miyazaki University School of Medicine; Miyazaki Japan

6. Department of Gastroenterological Surgery; Okayama University Graduate School of Medicine; Okayama Japan

7. Department of Digestive and Transplant Surgery; Tokushima University Graduate School of Medicine; Tokushima Japan

8. Department of Surgery; Tokyo Women's Medical University Medical Center East; Tokyo Japan

9. Department of Surgery; Ogori Dai-ichi General Hospital; Yamaguchi Japan

10. Department of Surgery; Kanmon Medical Center, NHO; Shimonoseki Japan

11. Department of Surgery; Shimonoseki Medical Center, JCHO; Shimonoseki Japan

12. Department of Pharmacy; Yamaguchi University Hospital; Ube Japan

13. Section of Hematology/Oncology; Department of Medicine; The University of Chicago; Chicago Illinois USA

14. Yamaguchi University; Yamaguchi Japan

Funder

Ministry of Health, Labour and Welfare

Project for Development of Innovative Research on Cancer Therapeutics (P-Direct)

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13113/fullpdf

Reference45 articles.

1. Vital Statistics in Japan Tabulated by Center for Cancer Control and Information Services, National Cancer Center, Japan 2013 http://ganjoho.jp/pro/statistics/en/table_download.html

2. Cancer statistics;Siegel;CA Cancer J Clin,2013

3. Monitoring of Cancer Incidence in Japan - Survival 2003-2005 Report 2013 http://ganjoho.jp/pro/statistics/en/table_download.html

4. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer;Rothenberg;Ann Oncol,1996

5. Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreatic cancer: a randomized trial;Burris;J Clin Oncol,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of vaccine immunotherapy for gastrointestinal cancers;Surgery Today;2023-12-03

2. The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers;Expert Review of Molecular Diagnostics;2023-11-10

3. Tumor vaccines: Toward multidimensional anti-tumor therapies;Human Vaccines & Immunotherapeutics;2023-10-31

4. The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities;The Journal of Pathology;2023-08

5. Application of VEGF/VEGFR peptide vaccines in cancer: A systematic review of clinical trials;Critical Reviews in Oncology/Hematology;2023-07